Shakuntala H. Mauzo

Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade

R. Amaria, S. Patel, M. Tetzlaff, 2019, International journal of dermatology.